Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05351333
NA

Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation

Sponsor: Spaulding Rehabilitation Hospital

View on ClinicalTrials.gov

Summary

The use of the conditioning open-label placebo (COLP) paradigm will be studied as a dose extension method to lower opioid dosage in patients with spinal cord injury, polytrauma, and burn injury. The goal is to provide the same level of pain relief with a reduced opioid intake to diminish side effects as well as the risk of addiction associated with opioid treatment.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2022-08-03

Completion Date

2026-07-31

Last Updated

2025-10-27

Healthy Volunteers

No

Interventions

OTHER

placebo

Sugar pill, with an essential-oil smell and of blue color used for conditioning.

Locations (1)

Spaulding Rehabilitation Hospital

Charlestown, Massachusetts, United States